USP14 inhibition corrects an in vivo model of impaired mitophagy

Abstract Mitochondrial autophagy or mitophagy is a key process that allows selective sequestration and degradation of dysfunctional mitochondria to prevent excessive reactive oxygen species, and activation of cell death. Recent studies revealed that ubiquitin–proteasome complex activity and mitochon...

Full description

Bibliographic Details
Main Authors: Joy Chakraborty, Sophia von Stockum, Elena Marchesan, Federico Caicci, Vanni Ferrari, Aleksandar Rakovic, Christine Klein, Angelo Antonini, Luigi Bubacco, Elena Ziviani
Format: Article
Language:English
Published: Springer Nature 2018-09-01
Series:EMBO Molecular Medicine
Subjects:
Online Access:https://doi.org/10.15252/emmm.201809014
_version_ 1827015098206519296
author Joy Chakraborty
Sophia von Stockum
Elena Marchesan
Federico Caicci
Vanni Ferrari
Aleksandar Rakovic
Christine Klein
Angelo Antonini
Luigi Bubacco
Elena Ziviani
author_facet Joy Chakraborty
Sophia von Stockum
Elena Marchesan
Federico Caicci
Vanni Ferrari
Aleksandar Rakovic
Christine Klein
Angelo Antonini
Luigi Bubacco
Elena Ziviani
author_sort Joy Chakraborty
collection DOAJ
description Abstract Mitochondrial autophagy or mitophagy is a key process that allows selective sequestration and degradation of dysfunctional mitochondria to prevent excessive reactive oxygen species, and activation of cell death. Recent studies revealed that ubiquitin–proteasome complex activity and mitochondrial membrane rupture are key steps preceding mitophagy, in combination with the ubiquitination of specific outer mitochondrial membrane (OMM) proteins. The deubiquitinating enzyme ubiquitin‐specific peptidase 14 (USP14) has been shown to modulate both proteasome activity and autophagy. Here, we report that genetic and pharmacological inhibition of USP14 promotes mitophagy, which occurs in the absence of the well‐characterised mediators of mitophagy, PINK1 and Parkin. Critical to USP14‐induced mitophagy is the exposure of the LC3 receptor Prohibitin 2 by mitochondrial fragmentation and mitochondrial membrane rupture. Genetic or pharmacological inhibition of USP14 in vivo corrected mitochondrial dysfunction and locomotion behaviour of PINK1/Parkin mutant Drosophila model of Parkinson's disease, an age‐related progressive neurodegenerative disorder that is correlated with diminished mitochondrial quality control. Our study identifies a novel therapeutic target that ameliorates mitochondrial dysfunction and in vivo PD‐related symptoms.
first_indexed 2024-03-07T17:58:27Z
format Article
id doaj.art-291aa43de92046d2919c57ef5223240c
institution Directory Open Access Journal
issn 1757-4676
1757-4684
language English
last_indexed 2025-02-18T14:18:35Z
publishDate 2018-09-01
publisher Springer Nature
record_format Article
series EMBO Molecular Medicine
spelling doaj.art-291aa43de92046d2919c57ef5223240c2024-10-28T08:56:29ZengSpringer NatureEMBO Molecular Medicine1757-46761757-46842018-09-01101111710.15252/emmm.201809014USP14 inhibition corrects an in vivo model of impaired mitophagyJoy Chakraborty0Sophia von Stockum1Elena Marchesan2Federico Caicci3Vanni Ferrari4Aleksandar Rakovic5Christine Klein6Angelo Antonini7Luigi Bubacco8Elena Ziviani9Department of Biology, University of PadovaFondazione Ospedale San Camillo IRCCSFondazione Ospedale San Camillo IRCCSDepartment of Biology, University of PadovaDepartment of Biology, University of PadovaInstitute of Neurogenetics, University of LübeckInstitute of Neurogenetics, University of LübeckDepartment of Neuroscience, University of PadovaDepartment of Biology, University of PadovaDepartment of Biology, University of PadovaAbstract Mitochondrial autophagy or mitophagy is a key process that allows selective sequestration and degradation of dysfunctional mitochondria to prevent excessive reactive oxygen species, and activation of cell death. Recent studies revealed that ubiquitin–proteasome complex activity and mitochondrial membrane rupture are key steps preceding mitophagy, in combination with the ubiquitination of specific outer mitochondrial membrane (OMM) proteins. The deubiquitinating enzyme ubiquitin‐specific peptidase 14 (USP14) has been shown to modulate both proteasome activity and autophagy. Here, we report that genetic and pharmacological inhibition of USP14 promotes mitophagy, which occurs in the absence of the well‐characterised mediators of mitophagy, PINK1 and Parkin. Critical to USP14‐induced mitophagy is the exposure of the LC3 receptor Prohibitin 2 by mitochondrial fragmentation and mitochondrial membrane rupture. Genetic or pharmacological inhibition of USP14 in vivo corrected mitochondrial dysfunction and locomotion behaviour of PINK1/Parkin mutant Drosophila model of Parkinson's disease, an age‐related progressive neurodegenerative disorder that is correlated with diminished mitochondrial quality control. Our study identifies a novel therapeutic target that ameliorates mitochondrial dysfunction and in vivo PD‐related symptoms.https://doi.org/10.15252/emmm.201809014mitochondrial membrane rupturemitophagyproteasomeUSP14
spellingShingle Joy Chakraborty
Sophia von Stockum
Elena Marchesan
Federico Caicci
Vanni Ferrari
Aleksandar Rakovic
Christine Klein
Angelo Antonini
Luigi Bubacco
Elena Ziviani
USP14 inhibition corrects an in vivo model of impaired mitophagy
EMBO Molecular Medicine
mitochondrial membrane rupture
mitophagy
proteasome
USP14
title USP14 inhibition corrects an in vivo model of impaired mitophagy
title_full USP14 inhibition corrects an in vivo model of impaired mitophagy
title_fullStr USP14 inhibition corrects an in vivo model of impaired mitophagy
title_full_unstemmed USP14 inhibition corrects an in vivo model of impaired mitophagy
title_short USP14 inhibition corrects an in vivo model of impaired mitophagy
title_sort usp14 inhibition corrects an in vivo model of impaired mitophagy
topic mitochondrial membrane rupture
mitophagy
proteasome
USP14
url https://doi.org/10.15252/emmm.201809014
work_keys_str_mv AT joychakraborty usp14inhibitioncorrectsaninvivomodelofimpairedmitophagy
AT sophiavonstockum usp14inhibitioncorrectsaninvivomodelofimpairedmitophagy
AT elenamarchesan usp14inhibitioncorrectsaninvivomodelofimpairedmitophagy
AT federicocaicci usp14inhibitioncorrectsaninvivomodelofimpairedmitophagy
AT vanniferrari usp14inhibitioncorrectsaninvivomodelofimpairedmitophagy
AT aleksandarrakovic usp14inhibitioncorrectsaninvivomodelofimpairedmitophagy
AT christineklein usp14inhibitioncorrectsaninvivomodelofimpairedmitophagy
AT angeloantonini usp14inhibitioncorrectsaninvivomodelofimpairedmitophagy
AT luigibubacco usp14inhibitioncorrectsaninvivomodelofimpairedmitophagy
AT elenaziviani usp14inhibitioncorrectsaninvivomodelofimpairedmitophagy